We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
-$36M
(-19%)
Cap. Flow
-$46M
Cap. Flow
% of AUM
-30.71%
Top 10 Holdings %
Top 10 Hldgs %
41.15%
Holding
341
New
79
Increased
30
Reduced
42
Closed
62
Avg Time Held Equity + Options
3.4
quarters
Top 10 Avg Time Held Equity + Options
1.8
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.7
quarters
Top 10 Avg Time Held Equity only
2.9
quarters
Top 20 Avg Time Held Equity only
3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.19M |
| 2 |
LL Flooring Holdings, Inc.
LL
|
+$1.02M |
| 3 |
McDonald's
MCD
|
+$949K |
| 4 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$869K |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$845K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$2.08M |
| 2 |
Esperion Therapeutics
ESPR
|
+$1.61M |
| 3 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
+$1.07M |
| 4 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$1.06M |
| 5 |
Loews
L
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.42% |
| 2 | Miscellaneous | 30.29% |
| 3 | Healthcare | 15.66% |
| 4 | Consumer Discretionary | 6.43% |
| 5 | Technology | 5.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
Casella Waste Systems
CWST
$5.42B
| $138K | 0.09% |
+25,000
| New | +$108K |
2015 Q1
0 quarters
|
|
152
FuelCell Energy
FCEL
$1.31B
| $138K | 0.09% |
25
-4
| -14% | -$22.2K |
2013 Q3
6 quarters
|
|
153
DELISTED
Cymabay Therapeutics
CBAY
| $138K | 0.09% |
20,000
-10,000
| -33% | -$96K |
2014 Q3
2 quarters
|
|
|
ZGNX
154
DELISTED
Zogenix, Inc.
ZGNX
| $137K | 0.09% |
+12,500
| New | +$141K |
2015 Q1
0 quarters
|
|
|
PRCP
155
DELISTED
Perceptron Inc
PRCP
| $135K | 0.09% |
+10,000
| New | +$113K |
2015 Q1
0 quarters
|
|
156
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $134K | 0.09% |
75,200
| – | – |
2013 Q2
7 quarters
|
|
|
EBSB
157
DELISTED
Meridian Bancorp, Inc.
EBSB
| $132K | 0.09% |
10,000
| – | – |
2014 Q3
2 quarters
|
|
|
RNDY
158
DELISTED
ROUNDYS INC COM STK
RNDY
| $122K | 0.08% |
25,000
-10,000
| -29% | -$42.5K |
2014 Q4
1 quarter
|
|
|
MDRX
159
DELISTED
Veradigm Inc. Common Stock
MDRX
| $120K | 0.08% |
10,000
-5,000
| -33% | -$61.1K |
2013 Q2
7 quarters
|
|
160
Crocs
CROX
$5.6B
| $118K | 0.08% |
+10,000
| New | +$112K |
2015 Q1
0 quarters
|
|
161
DELISTED
S&W Seed Co
SANW
| $116K | 0.08% |
+1,316
| New | +$114K |
2015 Q1
0 quarters
|
|
162
CALL
Alaunos Therapeutics
TCRT
$2.67M
| $108K | 0.07% |
+67
| New | +$99.3K |
2015 Q1
0 quarters
|
|
163
DELISTED
AMERICAN APPAREL INC COM
APP
| $105K | 0.07% |
150,000
| – | – |
2013 Q2
7 quarters
|
|
164
Fortress Biotech
FBIO
$70.4M
| $96K | 0.06% |
1,667
| – | – |
2013 Q2
7 quarters
|
|
|
AGRX
165
DELISTED
Agile Therapeutics
AGRX
| $93K | 0.06% |
+5
| New | +$87.6K |
2015 Q1
0 quarters
|
|
166
DELISTED
Bank Of America Corporation Ws B
BAC.WS.B
| $91K | 0.06% |
175,000
| – | – |
2013 Q2
7 quarters
|
|
167
The Bancorp
TBBK
$2B
| $90K | 0.06% |
10,000
-5,000
| -33% | -$45.5K |
2014 Q3
2 quarters
|
|
168
Hovnanian Enterprises
HOV
$617M
| $89K | 0.06% |
+1,000
| New | +$90.2K |
2015 Q1
0 quarters
|
|
169
Rigel Pharmaceuticals
RIGL
$912M
| $89K | 0.06% |
+2,500
| New | +$68.5K |
2015 Q1
0 quarters
|
|
|
ARIA
170
CALL
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $82K | 0.05% |
+10,000
| New | +$73.9K |
2015 Q1
0 quarters
|
|
|
DMK
171
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $79K | 0.05% |
+286
| New | +$124K |
2015 Q1
0 quarters
|
|
|
RTK
172
DELISTED
Rentech, Inc.
RTK
| $78K | 0.05% |
7,000
-2,000
| -22% | -$24.9K |
2013 Q2
7 quarters
|
|
173
Pure Cycle
PCYO
$271M
| $76K | 0.05% |
15,000
| – | – |
2013 Q2
7 quarters
|
|
174
NovaGold Resources
NG
$2.95B
| $74K | 0.05% |
25,000
| – | – |
2014 Q1
4 quarters
|
|
|
XCO
175
DELISTED
Exco Resources
XCO
| $73K | 0.05% |
2,667
| – | – |
2013 Q2
7 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2015 Portfolio in Review
As of Q1 2015, E.E. Geduld held 341 positions worth $150M, down 19% from $186M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
E.E. Geduld withdrew a net $46M in Q1 2015, closing 62 positions and reducing 42 holdings. Its most notable exit was Alibaba, an estimated $2.08M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, up from 31% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Celgene Corp worth $1.15M.
- E.E. Geduld's largest Q1 2015 buy was Celgene Corp: 10,000 shares worth $1.15M.
- E.E. Geduld added most to PHARMACYCLICS INC in Q1 2015, an estimated $869K increase.
- E.E. Geduld's biggest Q1 2015 reduction was Esperion Therapeutics, cutting an estimated $1.61M.
- E.E. Geduld fully exited Alibaba in Q1 2015, selling an estimated $2.08M.
- E.E. Geduld's ten largest holdings make up 41% of its $150M portfolio in Q1 2015.
- E.E. Geduld opened 79 new positions and closed 62 in Q1 2015.
- E.E. Geduld's portfolio value fell 19% quarter-over-quarter to $150M.
Based on E.E. Geduld's 13F filing for Q1 2015, filed 1 May 2015.